Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Symbenda Post-Marketing Surveillance (PMS)

NCT02434484

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Eisai Trial Site #7 Busan, South Korea
  • Eisai Trial Site #8 Busan, South Korea
  • Eisai Trial Site #6 Daegu, South Korea
  • Eisai Trial Site #4 Daejeon, South Korea
View Trial Details
Completed

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

NCT01380106

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Central Arkansas Veterans Healthcare System Little Rock, Arkansas, United States
  • West Los Angeles VA Medical Center Los Angeles, California, United States
  • Edward Hines Jr VA Hospital Hines, Illinois, United States
  • VA Boston Healthcare System Jamaica Plain, Massachusetts, United States
View Trial Details
Completed

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

NCT00621244

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center/University of Texas Houston, Texas, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View Trial Details

Related conditions